High Volume Manufacturing of Gateway-Class SSPAs for LEO Constellation
Gilat Awarded $9 Million in Orders for Support of Low Earth Orbit Constellation
June 28, 2021 07:07 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, June 28, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Gilat-SSPA-2021
Gilat Awarded Over $4 Million in Orders for Support of Low Earth Orbit Constellation
May 20, 2021 07:08 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 20, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Gilat-Chile+Telefonica-2021 v2
Telefonica Global Solutions (TGS) Selects Gilat to Equip Strategic Teleport in Arica, Chile
May 11, 2021 07:03 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 11, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Gilat Satellite Networks Logo
Gilat Awarded Over $20 Million in Orders for Support of Low Earth Orbit Constellation
April 19, 2021 07:08 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, April 19, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Vivet Therapeutics y Pfizer Inc reciben autorización de la FDA para iniciar GATEWAY, ensayo clínico de fase 1/2 con VTX-801, la terapia génica de Vivet para la enfermedad de Wilson
November 18, 2020 01:00 ET | Vivet Therapeutics
                                                                                                                                                    Vivet Therapeutics y Pfizer Inc reciben...
Vivet Therapeutics et Pfizer Inc. annoncent l’autorisation de la FDA de commencer l’étude de Phase 1/2 du VTX-801, GATEWAY, la thérapie génique expérimentale de Vivet pour la maladie de Wilson
November 18, 2020 01:00 ET | Vivet Therapeutics
                                                                                                                                                                                                        ...
Vivet Therapeutics and Pfizer Inc. Announce FDA Authorization to Proceed with GATEWAY, the Phase 1/2 Study for VTX-801, Vivet’s Investigational Gene Therapy for Wilson Disease
November 18, 2020 01:00 ET | Vivet Therapeutics
                                                                                                                                            Vivet Therapeutics and Pfizer...
ElectraMeccanica Logo 2020 (blue with bull) (002).jpg
ElectraMeccanica Partners with Gateway to Lead Expanded Investor Relations Program
June 23, 2020 08:31 ET | ElectraMeccanica Vehicles Corp.
VANCOUVER, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer and manufacturer of electric vehicles,...
lantronix_logo_tagline_lo-res.jpg
Lantronix to Showcase Its EMG-Edge Management Gateway at Cisco Live in Barcelona
January 23, 2020 06:00 ET | Lantronix, Inc.
BARCELONA, Spain, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Lantronix, Inc. (NASDAQ: LTRX), a global provider of secure data access and management solutions for the industrial Internet of Things (IoT), will...
FOGHORN LOGO.jpg
FogHorn Teams with Dell EMC OEM Solutions for the Industrial IoT Edge
November 13, 2018 11:00 ET | FogHorn Systems
Dell combines innovative industrial analytics and machine learning with trusted hardware for complete IIoT solutions SUNNYVALE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- FogHorn, a leading...